Aim immunotech's ampligen safety data presented at eighth european scientific working group on influenza

Ocala, fla., dec. 09, 2021 (globe newswire) -- aim immunotech inc. (nyse american: aim) today announced that safety data on its drug ampligen was recently presented at the eighth european scientific working group on influenza (eswi) virtual conference in salzburg, austria, on december 4-7, 2021. the conference also included research on covid-19 and respiratory syncytial virus.
AIM Ratings Summary
AIM Quant Ranking